Qube Research & Technologies LTD Ginkgo Bioworks Holdings, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 15,512,302 shares of DNA stock, worth $129 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,512,302Holding current value
$129 Million% of portfolio
0.01%Shares
4 transactions
Others Institutions Holding DNA
# of Institutions
347Shares Held
925MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.19 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.15 Billion0.0% of portfolio
-
Baillie Gifford & CO134MShares$1.12 Billion0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$580 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$349 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $10.7B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...